The preclinical and clinical pharmacology of SK&F 104353, a potent and selective peptidoleukotriene receptor antagonist.
Torphy
T J
TJ
SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406-0939.
Faiferman
I
I
Gleason
J G
JG
Hall
R F
RF
Lewis
M A
MA
Broom
C
C
Helfrich
H M
HM
Newton
J F
JF
Hay
D W
DW
D000485:Allergens; D000818:Animals; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D003998:Dicarboxylic Acids / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D066298:In Vitro Techniques; D008168:Lung / Q000187:drug effects / Q000502:physiology*; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology; D011971:Receptors, Immunologic / Q000037:antagonists & inhibitors*; D018077:Receptors, Leukotriene; D013189:SRS-A / Q000037:antagonists & inhibitors*; D014132:Trachea / Q000187:drug effects / Q000502:physiology
D000485:Allergens; D003998:Dicarboxylic Acids; D011971:Receptors, Immunologic; D018077:Receptors, Leukotriene; D013189:SRS-A; C052393:pobilukast